Showing 1141-1150 of 20397 results for "".
The Clinical Significance of Imaging in the Management of ADPKD
https://reachmd.com/programs/cme/clinical-significance-imaging-management-adpkd/12675/When managing patients with autosomal dominant polycystic kidney disease, what role does radiological imaging play?Options for an Infant with Atopic Dermatitis
https://reachmd.com/programs/cme/options-for-an-infant-with-ad/11242/A mutlidisciplinary panel discusses treatment options for an infant with severe, refractory atopic dermatitis.Immunotherapy: Changing Patient Outcomes in SCLC
https://reachmd.com/programs/cme/immunotherapy-changing-patient-outcomes-in-sclc/10710/This activity offers expert insight into the practice-changing evidence on immunotherapy for the management of extensive-stage small cell lung cancer.Updates in Major Depressive Disorder with Insomnia
https://reachmd.com/programs/cme/updates-in-major-depressive-disorder-with-insomnia/36556/Join us to learn about the emerging data in the management of major depressive disorder with insomnia.IBD Immunopathogenesis: Do You Know What You're Blocking?
https://reachmd.com/programs/cme/ibd-immunopathogenesis-do-you-know-what-youre-blocking/51482/Explore IBD from diagnosis to remission with practical cases, treatment strategies, and a treat-to-target approach for optimal patient outcomes.Navigating KDIGO Practice Guideline Recommendations to Maximize Proteinuria Reduction in Patients With IgAN
https://reachmd.com/programs/cme/navigating-upated-kdigo-clinical-practice-guideline-recommndations-to-maximize-proteinuria-reduction-in-patients-with-igan/26630/Explore updated KDIGO guideline recommendations and clinical strategies to reduce proteinuria in patients with IgA nephropathy.IBD in Focus: A Case-Based Approach to Diagnosis and Assessment
https://reachmd.com/programs/cme/ibd-in-focus-a-case-based-approach-to-diagnosis-and-assessment/49150/Discuss diagnostic evaluation and severity assessment in a case of suspected IBD using clinical, laboratory, endoscopic, and imaging data.Evaluating Use in Pancreatic Cancer: Efficacy and Safety Data for ON-State RAS Inhibitors
https://reachmd.com/programs/cme/evaluating-use-in-pancreatic-cancer-efficacy-and-safety-data-for-on-state-ras-inhibitors/54122/Explore ON-state RAS inhibitors for the treatment of NSCLC and pancreatic cancer, including mechanisms, efficacy data, and integration into clinical practice.Truths and Myths About Facial Danger Zones When Injecting Soft Tissue Fillers
https://reachmd.com/programs/modern-aesthetics/truths-and-myths-about-facial-danger-zones-when-injecting-soft-tissue-fillers/39264/Despite the current dip in demand for aesthetic treatments with soft tissue fillers, minimally invasive procedures remain popular and are widely accepted as alternatives to facial surgery.Gut Microbiota and Pediatric MS: New Insights Into Potential Disease Drivers
https://reachmd.com/programs/neurofrontiers/gut-microbiota-and-pediatric-ms-new-insights-into-potential-disease-drivers/26487/A new study investigating the relationship between gut microbiota composition and pediatric-onset multiple sclerosis (MS) offers evidence that a depletion of short-chain fatty acid (SCFA) producers may play a role in the disease's pathogenesis. Discover how these findings have the potential to infor